Inflammasomes and metabolic disorders

Old genes in modern diseases

Gregory R. Robbins, Haitao Wen, Jenny P.Y. Ting

Research output: Contribution to journalReview article

52 Citations (Scopus)

Abstract

Modern medical and hygienic practices have greatly improved human health and longevity; however, increased human life span occurs concomitantly with the emergence of metabolic and age-related diseases. Studies over the past decade have strongly linked host inflammatory responses to the etiology of several metabolic diseases including atherosclerosis, type 2 diabetes (T2D), obesity, and gout. A common immunological factor to these diseases is the activation of the inflammasome and release of proinflammatory cytokines that promote disease progression. Here we review the molecular mechanism(s) of inflammasome activation in response to metabolic damage-associated molecular patterns (DAMPs) and discuss potential targets for therapeutic intervention.

Original languageEnglish (US)
Pages (from-to)297-308
Number of pages12
JournalMolecular Cell
Volume54
Issue number2
DOIs
StatePublished - Apr 24 2014

Fingerprint

Inflammasomes
Gout
Metabolic Diseases
Immunologic Factors
Type 2 Diabetes Mellitus
Genes
Disease Progression
Atherosclerosis
Obesity
Cytokines
Health
Therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Inflammasomes and metabolic disorders : Old genes in modern diseases. / Robbins, Gregory R.; Wen, Haitao; Ting, Jenny P.Y.

In: Molecular Cell, Vol. 54, No. 2, 24.04.2014, p. 297-308.

Research output: Contribution to journalReview article

Robbins, Gregory R. ; Wen, Haitao ; Ting, Jenny P.Y. / Inflammasomes and metabolic disorders : Old genes in modern diseases. In: Molecular Cell. 2014 ; Vol. 54, No. 2. pp. 297-308.
@article{d961edfc2a9e41ea8973f119400a2cdd,
title = "Inflammasomes and metabolic disorders: Old genes in modern diseases",
abstract = "Modern medical and hygienic practices have greatly improved human health and longevity; however, increased human life span occurs concomitantly with the emergence of metabolic and age-related diseases. Studies over the past decade have strongly linked host inflammatory responses to the etiology of several metabolic diseases including atherosclerosis, type 2 diabetes (T2D), obesity, and gout. A common immunological factor to these diseases is the activation of the inflammasome and release of proinflammatory cytokines that promote disease progression. Here we review the molecular mechanism(s) of inflammasome activation in response to metabolic damage-associated molecular patterns (DAMPs) and discuss potential targets for therapeutic intervention.",
author = "Robbins, {Gregory R.} and Haitao Wen and Ting, {Jenny P.Y.}",
year = "2014",
month = "4",
day = "24",
doi = "10.1016/j.molcel.2014.03.029",
language = "English (US)",
volume = "54",
pages = "297--308",
journal = "Molecular Cell",
issn = "1097-2765",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - Inflammasomes and metabolic disorders

T2 - Old genes in modern diseases

AU - Robbins, Gregory R.

AU - Wen, Haitao

AU - Ting, Jenny P.Y.

PY - 2014/4/24

Y1 - 2014/4/24

N2 - Modern medical and hygienic practices have greatly improved human health and longevity; however, increased human life span occurs concomitantly with the emergence of metabolic and age-related diseases. Studies over the past decade have strongly linked host inflammatory responses to the etiology of several metabolic diseases including atherosclerosis, type 2 diabetes (T2D), obesity, and gout. A common immunological factor to these diseases is the activation of the inflammasome and release of proinflammatory cytokines that promote disease progression. Here we review the molecular mechanism(s) of inflammasome activation in response to metabolic damage-associated molecular patterns (DAMPs) and discuss potential targets for therapeutic intervention.

AB - Modern medical and hygienic practices have greatly improved human health and longevity; however, increased human life span occurs concomitantly with the emergence of metabolic and age-related diseases. Studies over the past decade have strongly linked host inflammatory responses to the etiology of several metabolic diseases including atherosclerosis, type 2 diabetes (T2D), obesity, and gout. A common immunological factor to these diseases is the activation of the inflammasome and release of proinflammatory cytokines that promote disease progression. Here we review the molecular mechanism(s) of inflammasome activation in response to metabolic damage-associated molecular patterns (DAMPs) and discuss potential targets for therapeutic intervention.

UR - http://www.scopus.com/inward/record.url?scp=84899140315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899140315&partnerID=8YFLogxK

U2 - 10.1016/j.molcel.2014.03.029

DO - 10.1016/j.molcel.2014.03.029

M3 - Review article

VL - 54

SP - 297

EP - 308

JO - Molecular Cell

JF - Molecular Cell

SN - 1097-2765

IS - 2

ER -